AGBT
At last week's AGBT meeting, the companies showcased new chemistries that turn their flow cells into stages for RNA, protein, and cellular analysis.
The mid-throughput platform, to be launched initially in the US, is Complete Genomics' first sequencer that is optimized for the antibody-based CoolMPS chemistry.
The IconPCR instrument can control the temperature of each well independently while combining DNA quantification, amplification, and normalization into one integrated workflow.
The new chip, presented at AGBT among other updates, should double the number of cells per channel while improving sensitivity and recovery, among other benefits.
The Cambridge, Massachusetts-based company unveiled its first instrument, Callisto, at the Advances in Genome Biology and Technology annual meeting this week.